Literature DB >> 10559366

High viral load in the cerebrospinal fluid and brain correlates with severity of simian immunodeficiency virus encephalitis.

M C Zink1, K Suryanarayana, J L Mankowski, A Shen, M Piatak, J P Spelman, D L Carter, R J Adams, J D Lifson, J E Clements.   

Abstract

AIDS dementia and encephalitis are complications of AIDS occurring most frequently in patients who are immunosuppressed. The simian immunodeficiency virus (SIV) model used in this study was designed to reproducibly induce AIDS in macaques in order to examine the effects of a neurovirulent virus in this context. Pigtailed macaques (Macaca nemestrina) were coinoculated with an immunosuppressive virus (SIV/DeltaB670) and a neurovirulent molecularly cloned virus (SIV/17E-Fr), and more than 90% of the animals developed moderate to severe encephalitis within 6 months of inoculation. Viral load in plasma and cerebrospinal fluid (CSF) was examined longitudinally to onset of AIDS, and viral load was measured in brain tissue at necropsy to examine the relationship of systemic and central nervous system (CNS) viral replication to the development of encephalitis. In all animals, plasma viral load peaked at 10 to 14 days postinfection and remained high throughout infection with no correlation found between plasma viremia and SIV encephalitis. In contrast, persistent high levels of CSF viral RNA after the acute phase of infection correlated with the development of encephalitis. Although high levels of viral RNA were found in the CSF of all macaques (six of six) during the acute phase, this high level was maintained only in macaques developing SIV encephalitis (five of six). Furthermore, the level of both viral RNA and antigen in the brain correlated with the severity of the CNS lesions. The single animal in this group that did not have CNS lesions had no detectable viral RNA in any of the regions of the brain. The results substantiate the use of CSF viral load measurements in the postacute phase of SIV infection as a marker for encephalitis and CNS viral replication.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10559366      PMCID: PMC113103     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  Pathogenesis of simian immunodeficiency virus encephalitis: viral determinants of neurovirulence.

Authors:  J L Mankowski; M T Flaherty; J P Spelman; D A Hauer; P J Didier; A M Amedee; M Murphey-Corb; L M Kirstein; A Muñoz; J E Clements; M C Zink
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  Molecular and biological characterization of a neurovirulent molecular clone of simian immunodeficiency virus.

Authors:  M T Flaherty; D A Hauer; J L Mankowski; M C Zink; J E Clements
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

3.  Plasma SIV RNA viral load determination by real-time quantification of product generation in reverse transcriptase-polymerase chain reaction.

Authors:  K Suryanarayana; T A Wiltrout; G M Vasquez; V M Hirsch; J D Lifson
Journal:  AIDS Res Hum Retroviruses       Date:  1998-01-20       Impact factor: 2.205

4.  Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection.

Authors:  J W Mellors; A Muñoz; J V Giorgi; J B Margolick; C J Tassoni; P Gupta; L A Kingsley; J A Todd; A J Saah; R Detels; J P Phair; C R Rinaldo
Journal:  Ann Intern Med       Date:  1997-06-15       Impact factor: 25.391

5.  Pathogenesis of SIV encephalitis. Selection and replication of neurovirulent SIV.

Authors:  M C Zink; A M Amedee; J L Mankowski; L Craig; P Didier; D L Carter; A Muñoz; M Murphey-Corb; J E Clements
Journal:  Am J Pathol       Date:  1997-09       Impact factor: 4.307

6.  Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. HIV Neurobehavioral Research Center Group.

Authors:  R J Ellis; K Hsia; S A Spector; J A Nelson; R K Heaton; M R Wallace; I Abramson; J H Atkinson; I Grant; J A McCutchan
Journal:  Ann Neurol       Date:  1997-11       Impact factor: 10.422

7.  Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain.

Authors:  J C McArthur; D R McClernon; M F Cronin; T E Nance-Sproson; A J Saah; M St Clair; E R Lanier
Journal:  Ann Neurol       Date:  1997-11       Impact factor: 10.422

8.  Cerebrospinal fluid HIV-1 RNA levels: correlation with HIV encephalitis.

Authors:  P Cinque; L Vago; D Ceresa; F Mainini; M R Terreni; A Vagani; W Torri; S Bossolasco; A Lazzarin
Journal:  AIDS       Date:  1998-03-05       Impact factor: 4.177

9.  Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara.

Authors:  V M Hirsch; T R Fuerst; G Sutter; M W Carroll; L C Yang; S Goldstein; M Piatak; W R Elkins; W G Alvord; D C Montefiori; B Moss; J D Lifson
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

10.  Quantitation of human immunodeficiency virus in brains of demented and nondemented patients with acquired immunodeficiency syndrome.

Authors:  R T Johnson; J D Glass; J C McArthur; B W Chesebro
Journal:  Ann Neurol       Date:  1996-03       Impact factor: 10.422

View more
  130 in total

1.  HIV and HIV dementia.

Authors:  D L Kolson; F González-Scarano
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

Review 2.  Human immunodeficiency virus-associated dementia: an evolving disease.

Authors:  Justin C McArthur; Norman Haughey; Suzanne Gartner; Kathy Conant; Carlos Pardo; Avi Nath; Ned Sacktor
Journal:  J Neurovirol       Date:  2003-04       Impact factor: 2.643

3.  Role of microglial cells in selective replication of simian immunodeficiency virus genotypes in the brain.

Authors:  Tahar Babas; Daniel Muñoz; Joseph L Mankowski; Patrick M Tarwater; Janice E Clements; M Christine Zink
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

Review 4.  Monocyte mobilization, activation markers, and unique macrophage populations in the brain: observations from SIV infected monkeys are informative with regard to pathogenic mechanisms of HIV infection in humans.

Authors:  Kenneth Williams; Tricia H Burdo
Journal:  J Neuroimmune Pharmacol       Date:  2011-12-14       Impact factor: 4.147

Review 5.  Lentiviral neuropathogenesis: comparative neuroinvasion, neurotropism, neurovirulence, and host neurosusceptibility.

Authors:  Megan K Patrick; James B Johnston; Christopher Power
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

6.  High frequency of virus-specific CD8+ T cells in the central nervous system of macaques chronically infected with simian immunodeficiency virus SIVmac251.

Authors:  Marcin Moniuszko; Charlie Brown; Ranajit Pal; Elzbieta Tryniszewska; Wen-Po Tsai; Vanessa M Hirsch; Genoveffa Franchini
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

Review 7.  Editorial neuroAIDS review.

Authors:  Paul Shapshak; Pandjassarame Kangueane; Robert K Fujimura; Deborah Commins; Francesco Chiappelli; Elyse Singer; Andrew J Levine; Alireza Minagar; Francis J Novembre; Charurut Somboonwit; Avindra Nath; John T Sinnott
Journal:  AIDS       Date:  2011-01-14       Impact factor: 4.177

8.  PrPC, the cellular isoform of the human prion protein, is a novel biomarker of HIV-associated neurocognitive impairment and mediates neuroinflammation.

Authors:  Toni K Roberts; Eliseo A Eugenin; Susan Morgello; Janice E Clements; M Christine Zink; Joan W Berman
Journal:  Am J Pathol       Date:  2010-08-19       Impact factor: 4.307

9.  Longitudinal analysis of monocyte/macrophage infection in simian immunodeficiency virus-infected, CD8+ T-cell-depleted macaques that develop lentiviral encephalitis.

Authors:  Stephanie J Bissel; Guoji Wang; Anita M Trichel; Michael Murphey-Corb; Clayton A Wiley
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

10.  RON receptor tyrosine kinase, a negative regulator of inflammation, is decreased during simian immunodeficiency virus-associated central nervous system disease.

Authors:  Daniele C Cary; Janice E Clements; Andrew J Henderson
Journal:  J Immunol       Date:  2013-09-16       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.